Serum Institute

AstraZeneca has admitted in court documents that its Covid-19 vaccine, developed in collaboration with Oxford University and manufactured as Covishield in India, can cause a rare and dangerous side effect known as Thrombosis with Thrombocytopenia Syndrome.  Pharmaceutical giant on Wednesday further announced the global withdrawal of its vaccine. The Serum Institute and the Indian government are yet to make a comment on the development.